Scalable Liquid-Liquid Encapsulation for Drug Delivery

用于药物输送的可扩展液-液封装

• 批准号: 572809-2022
• 负责人: Mitra, SushantaKSK
• 金额: $ 1.82万
• 依托单位: University of Waterloo
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-01-01 至 2023-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=760374
• 关键词: Scalable; Liquid; Encapsulation; Drug; Delivery

Developing a fast, scalable encapsulation technique with high throughput and flexible yet stable core-shell combination is a current bottleneck for the pharmaceutical industry. This Alliance International proposal addresses this challenge by bringing together researchers from the University of Waterloo and Technical University Eindhoven. The proposed activities during the one-year project include organizing a summer school in hybrid mode on Frontiers of Encapsulation Technology, performing collaborative research involving PIs and HQP to deliver on the project objectives and working towards other funding opportunities to sustain this collaborative partnership beyond one year. The successful completion of the proposed activities would create opportunities to accelerate the biomanufacturing priorities of the province, enable international trade with the European Union and create cost-effective pharmaceutical formulations for vulnerable populations locally and globally.

开发具有高通量和灵活而稳定的核-壳组合的快速、可扩展的封装技术是制药工业当前的瓶颈。这个国际联盟的建议通过汇集滑铁卢大学和埃因霍温技术大学的研究人员来解决这一挑战。在为期一年的项目期间，拟议的活动包括以混合模式组织一个关于封装技术前沿的暑期学校，进行涉及PI和HQP的合作研究，以实现项目目标，并争取其他资助机会，以维持这种合作伙伴关系超过一年。拟议活动的成功完成将创造机会，加快该省的生物制造优先事项，实现与欧洲联盟的国际贸易，并为当地和全球的弱势群体创造具有成本效益的药物配方。